This biophysical study demonstrates for the first time that the Ca2+-ATPase molecule is composed of distinct domains with considerably different mobilities that are modulated by calcium binding and membrane interactions.
This is the authors' abstract. We don't add key points for this paper.
The Ca2+-transporting ATPase of rabbit skeletal muscle sarcoplasmic reticulum was site-specifically labeled with either N-(1-anilinonaphth-4-yl)maleimide (ANM) or 5-[[(iodoacetamido)-ethyl]amino]naphthalene-1-sulfonate (IAEDANS), and the segmental motion of submolecular domains of the ATPase molecule was examined by means of time-resolved and steady-state fluorescence anisotropy measurements. The ANM-binding domain showed wobbling with a rotational relaxation time phi = 69 ns in the absence of free Ca2+ without any independent wobbling of the ANM moiety. The IAEDANS-binding domain showed a significantly slower wobbling with phi = 190 ns in the absence of Ca2+. The present results demonstrated for the first time that the ATPase molecule is composed of distinct domains whose mobilities are considerably different from each other. The binding of Ca2+ to the transport site increased the segmental motion of ANM-labeled domain, leading to a phi value of 65 ns. Solubilization of the ANM-labeled SR membranes by deoxycholate led to a further increase in the segmental flexibility (phi = 48 ns in the absence of free Ca2+), indicating that the mobility of the ANM-binding domain was considerably restricted through interaction with the membrane. The mobility of the ANM-binding domain of solubilized ATPase was also increased to some extent upon binding of Ca2+.
Answers are grounded in this paper and cite their sources.
Preclinical Ca2+-ATPase domain dynamics warrant no clinical change; leaves open cardiac SERCA modeling in HF.
No takes yet. Share an insight, caveat, or question.
Suzuki et al. (1989) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: